NK cell proliferation and inflammation

Immunology and Cell Biology

Volumn 74, Issue 5, 1996, Pages 473-480

  Warren, Hilary S ^a  

^a WODEN VALLEY HOSPITAL   (Australia)

Author keywords

Cytokines; Cytotoxicity; Inflammation; NK cells

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 2;

CYTOTOXICITY; HUMAN; INFLAMMATION; LYMPHOCYTE MIGRATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; REVIEW; VIRUS INFECTION;

EID: 0029841473     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1038/icb.1996.78     Document Type: Review

References (120)

1. Trinchieri G. Biology of human natural killer cells. Adv. Immunol. 1989; 47: 187-376.
2. Carson WE, Giri JG, Lindemann MJ et al. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J. Exp. Med. 1994; 180: 1395-403.
3. Aste-Amezaga M, D'Andrea A, Kubin M, Trinchieri G. Cooperation of natural killer cell stimulatory factor/interleukin-12 with other stimuli in the induction of cytokines and cytotoxic cell-associated molecules in human T and NK cells. Cell. Immunol. 1994; 156: 480-92.
4. Trinchieri G. Interleukin-12: A proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Ann. Rev. Immunol. 1995; 13: 251-76.
5. Carson WE, Ross ME, Baiocchi RA et al. Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-γ by natural killer cells in vitro. J. Clin. Invest. 1995; 96: 2578-82.
6. Doherty TM, Seder RA, Sher A. Induction and regulation of IL-15 expression in murine macrophages. J. Immunol. 1996; 156: 735-41.
7. dim) human NK cells. J. Immunol. 1996; 156: 3254-9.
8. Nagler A, Lanier LL, Cwirla S, Phillips JH. Comparative studies of human FcRIII-positive and negative natural killer cells. J. Immunol. 1989; 143: 3183-91.
9. + small resting lymphocytes by culture with autologous T cell blasts and lymphokine. J. Immunol. 1984; 132: 2888-94.
10. Warren HS, Kinnear BF, Skipsey LJ. Human natural killer (NK) cells: Requirements for cell proliferation and expansion of phenotypically novel subpopulations. Immunol. Cell Biol. 1993; 71: 87-97.
11. Inverardi L, Witson JC, Fuad SA, Winklerpickett RT, Ortaldo JR, Bach FH. CD3 negative 'small agranular lymphocytes' are natural killer cells. J. Immunol. 1991; 146: 4048-52.
12. Lanier LL, Phillips JH. Evidence for three types of human cytotoxic lymphocytes. Immunol. Today 1986; 7: 132-4.
13. Spits H, Lanier LL, Phillips JH. Development of human T and natural killer cells. Blood 1995; 85: 2654-70.
14. Anderson P, Caligiuri M, O'Brien C, Manley T, Ritz J, Schlossman SF. Feγ receptor type III (CD16) is included in the ζ NK receptor complex expressed by human NK cells. Proc. Natl Acad. Sci. USA 1990; 87: 2274-8.
15. Altin JG, Pagler EB, Kinnear BF, Warren HS. Molecular associations involving CD16, CD45 and ζ and γ chains on human natural killer cells. Immunol. Cell Biol. 1994; 72: 87-96.
16. Lanier LL, Phillips JH, Hackett JJ, Tutt M, Kumar V. Natural killer cells: Definition of a cell type rather than a function. J. Immunol. 1986; 137: 2735-9.
17. + T-lymphocytes. II. Modulation of natural killer cytotoxicity by anti-Kp43 monoclonal antibody. J. Immunol. 1991; 147: 714-21.
18. Lanier LL, Chang CW, Phillips JH. Human NKR-P1A: A disulfide-linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes. J. Immunol. 1994; 153: 2417-28.
19. Valiante NM, Trinchieri G. Identification of a novel signal transduction surface molecule on human cytotoxic lymphocytes. J. Exp. Med. 1993; 178: 1397-406.
20. Kasai M, Iwamori M, Nagai Y, Okumura K, Tada T. A glycolipid on the surface of mouse natural killer cells. Eur. J. Immunol. 1980; 10: 175-80.
21. Ryan JC, Turck J, Niemi EC, Yokoyama WM, Seaman WE. Molecular cloning of the NK1.1 antigen, a member of the NKR-P1 family of natural killer cell activation molecules. J. Immunol. 1991; 149: 1631-5.
22. Gosselin P, Lusignan Y, Lemieux S. The murine NK2.1 antigen: a 130kDa glycoprotein dimer expressed by a natural killer cell subset of the spleen, thymus and lymph nodes. Molec. Immunol. 1993; 30: 1185-93.
23. M1 expression with increased total cellular RNA and protein content in normal thymocyte and spleen cell populations. J. Immunol. 1987; 139: 2123-9.
24. + T cells. Curr. Opin. Immunol. 1995; 7: 367-74.
25. + T cells: a new family of T cells. Immunol. Today 1996; 17: 71-6.
26. Chambers WH, Vujanovic NL, DeLeo AB, Olszowy MW, Herberman RB, Hiserodt JC. Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine activated killer cells. J. Exp. Med. 1989; 169: 1373-89.
27. Chambers WH, DeLeo AB, Vujanovic NL, Herberman RB, Olszowsky MW. Characterisation and functional significance of NKR-P1 (3.2.3 antigen): a novel triggering molecule. In: Lotzova E, Herberman RB (eds). NK Cell Mediated Cytotoxicity: Receptors, Signalling and Mechanisms. Boca Raton: CRC Press, 1992: 169-81.
28. - large granular lymphocytes. J. Exp. Med. 1991; 174: 1527-36.
29. Anderson SK, Gallinger S, Roder J, Frey J, Young HA, Ortaldo JR. A cyclophilin-related protein involved in the function of natural killer cells. Proc. Natl Acad. Sci. USA 1993; 90: 542-6.
30. Duchler M, Offterdinger M, Holzmuller H et al. NKG2-C is a receptor on human natural killer cells that recognizes structures on K562 target cells. Eur. J. Immunol. 1995; 25: 2923-31.
31. Lanier LL, Phillips JH. Inhibitory MHC class I receptors on NK cells and T cells, Immunol. Today 1996; 17: 86-91.
32. Moretta L, Ciccone E, Mingari MC, Biassoni R, Moretta A. Human natural killer cells: Origin, clonality, specificity, and receptors. Adv. Immunol. 1994; 55: 341-80.
33. Wagtmann N, Biassoni R, Cantoni C et al. Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains. Immunity 1995; 2: 439-49.
34. D'Andrea A, Chang C, Franz-Bacon K, McClanahan T, Phillips JH, Lanier LL. Molecular cloning of NKB1 - A natural killer cell receptor for HLA-B allotypes. J. Immunol. 1995; 155: 2306-10.
35. Dohring C, Scheidegger D, Samaridis J, Cella M, Colonna M. A human natural killer inhibitory receptor specific for HLA-A. J Immunol. 1996; 156: 3098-101.
36. Biassoni R, Cantoni C, Falco M et al. The human leukocyte antigen (HLA)-C-specific 'activatory' or 'inhibitory' natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions. J. Exp. Med. 1996; 183: 645-50.
37. Moretta A, Sivori S, Vitale M et al. Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells. J. Exp. Med. 1995; 182: 875-84.
38. Litwin V, Gumperz J, Parham P, Phillips JH, Lanier LL. Specificity of HLA class-I antigen recognition by human NK clones: Evidence for clonal heterogeneity, protection by self and non-self alleles, and influence of the target cell type. J. Exp. Med. 1993; 178: 1321-36.
39. Phillips JH, Gumperz JE, Parham P. Lanier LL. Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes. Science 1995; 268: 403-5.
40. Yokoyama WM, Seaman WE. The Ly-49 and NKR-P1 gene families encoding lectin-like receptors on natural killer cells: The NK gene complex. Ann. Rev. Immunol. 1993; 11: 613-35.
41. Yokoyama WM, Daniels BF, Seaman WE, Hunzinker R, Margulies DH, Smith HRC. A family of murine NK cell receptors specific for target cell MHC class I molecules. Sem. Immunol. 1995; 7: 89-101.
42. Sentman CL, Olsson MY, Karre K. Missing self recognition by natural killer cells in MHC class I transgenic mice. A 'receptor calibration' model for how effector cells adapt to self. Sem. Immunol. 1995; 7: 109-19.
43. Warren HS, Kinnear BF, Phillips JH, Lanier LL. Production of IL-5 by human NK cells and regulation of IL-5 secretion by IL-4, IL-10, and IL-12. J. Immunol. 1995; 154: 5144-52.
44. Somersalo K, Carpen O, Saksela E. Stimulated natural killer cells secrete factors with chemotactic activity, including NAP-1 IL-8, which supports VLA-4- and VLA-5-mediated migration of T lymphocytes. Eur. J. Immunol. 1994; 24: 2957-65.
45. Hsu DH, Moore KW, Spits H. Differential effects of IL-4 and IL-10 on IL-2-induced IFN-γ synthesis and lymphokine-activated killer activity. Int. Immunol. 1992; 4: 563-9.
46. Rolstad B, Herberman RB, Reynolds CW. Natural killer cells in the rat. V. The circulation patterns and tissue localisation of peripheral blood large granular lymphocytes (LGL). J. Immunol. 1986; 136: 2800-8.
47. Timonen T, Saksela E. Isolation of human NK cells by density gradient centrifugation. J. Immunol. Meth. 1980; 36: 285-91.
48. Witte T, Wordelmann K, Schmidt RE. Heterogeneity of human natural killer cells in the spleen. Immunology 1989; 69: 166-70.
49. Vivier E, Munroe M, Ariniello P, Anderson P. Identification of tissue-infiltrating lymphocytes expressing PENS, a mucin-like glycoprotein selectively expressed on natural killer cells. Am. J. Pathol. 1995; 146: 409-18.
50. Kummer JA, Kamp AM, Tadema TM, Vos W, Meijer CJLM, Hack CE. Localization and identification of granzymes A and B-expressing cells in normal human lymphoid tissue and peripheral blood. Clin. Exp. Immunol. 1995; 100: 164-72.
51. + natural killer cells in tissues from normal and tumour-bearing rats. Cancer Res. 1991; 51: 4931-6.
52. Winnock M, Lafon M-E, Boulard A et al. Characterization of liver-associated natural killer cells in patients with liver tumors. Hepatol. 1991; 13: 676-82.
53. Luo DZ, Vanderkerken K, Bouwens L, Kuppen PJK, Crabbe E, Wisse E. The number and distribution of hepatic natural killer cells (pit cells) in normal rat liver: An immunohistochemical study. Hepatol. 1995; 21: 1690-4.
54. + T cells in humans: Their abundance in the liver and similarity to extrathymic T cells in mice. Biomed. Res. 1995; 16: 1-9.
55. Vivier E, Sorrell JM, Ackerly M et al. Developmental regulation of a mucin-like glycoprotein selectively expressed on natural killer cells. J. Exp. Med. 1993; 178: 2023-33.
56. Wiltrout RH, Mathieson BJ, Talmadge JE et al. Augmentation of organ-associated natural killer activity by biological response modifiers. Isolation and characterization of large granular lymphocytes from the liver. J. Exp. Med. 1984; 160: 1431-49.
57. Croy BA. Granulated metrial gland cells: Hypotheses concerning possible functions during murine gestation. J. Reprod. Immunol. 1994; 27: 85-94.
58. + cells in the rat uterus: Granulated metrial gland cells are of the natural killer cell lineage. Biol. Reprod. 1994; 51: 509-23.
59. Dietl J, Ruck P, Marzusch K, Horny H-P, Kaisetling E, Handgretninger R. Uterine granular lymphocytes are activated natural killer cells. Immunol. Today 1992; 13: 236.
60. + natural killer cells with high affinity interleukin 2 receptors in human early pregnancy decidua. Int. Immunol. 1991; 3: 743-50.
61. + NK cells implies they are activated and capable of effector functions. Human Reprod. 1993; 8: 2061-7.
62. King A, Loke YW. On the nature and function of human uterine large granular lymphocytes. Immunol. Today 1991; 12: 432-5.
63. - decidual and peripheral blood leukocytes. J. Immunol. 1994; 152: 4255-61.
64. Hogan PG, Hapel AJ, Doe WF. Lymphokine-activated killer cell activity in human intestinal mucosa. J. Immunol. 1985; 135: 1731-8.
65. - large granular lymphocytes generated from human duodenal mucosa. Immunology 1993; 79: 498-505.
66. + cells with different phenotypes in lymphatic tissues and blood. Scand. J. Immunol. 1983; 18: 485-93.
67. Callol L, Coca S, Chillon MJ, Villegas F, Moreno-Muro F, Gomez-Terreros FJ. NK cells in non-neoplastic lung tissue. Initial results. Resp. Med. 1995; 89: 77.
68. Richter N, Raddatz G, Steinhoff G, Schafers HJ, Schlitt HJ. Transmission of donor lymphocytes in clinical lung transplantation. Transplant. Internat. 1994; 7: 414-19.
69. Yano T, Murata M, Ishida T et al. Phenotypic characterisation of lymphokine-activated killer cells from human lymph node lymphocytes. Cell Immunol. 1989; 122: 578-84.
70. Nakashima M, Janiszewska M, Steplewski Z, Watanabe T, Schuchter L, Koprowski H. Proliferation, phenotype, and cytotoxicity of human lymphocytes isolated from lymph nodes invaded by melanoma cells. Hybridoma 1994; 13: 241-6.
71. Kummer JA, Tak PP, Brinkman BMN et al. Expression of granzymes A and B in synovial tissue from patients with rheumatoid arthritis and osteoarthritis. Clin. Immunol. Immunopath. 1994; 73: 88-95.
72. Sieper J, Kingsley G. Recent advances in the pathogenesis of reactive arthritis. Immunol. Today 1996; 17: 160-3.
73. Tarkkanen J, Saksela E, Lanier LL. Bacterial activation of human natural killer cells. Characteristics of the activation process and identification of the effector cell. J. Immunol. 1986; 137: 2428-33.
74. Kettering JD, Torabinejad M. Presence of natural killer cells in human chronic periapical lesions. Int. Endodontic J. 1993; 26: 344-7.
75. Maenpaa A, Jaaskelainen J, Carpern O, Patarroyo M, Timonen T. Expression of integrins and other adhesion molecules on NK cells; impact of IL-2 on short- and long-term cultures. Int. J. Cancer 1993; 53: 850-5.
76. Pinola M, Saksela E, Tiisala S, Renkonen R. Human NK cells expressing α4β1/β7 adhere to VCAM-1 without preactivation. Scand. J. Immunol. 1994; 39: 131-6.
77. Bianchi G, Sironi M, Ghibaudi E et al. Migration of natural killer cells across endothelial cell monolayers. J. Immunol. 1993; 151: 5135-44.
78. 1 integrins. Blood 1995; 85: 1858-64.
79. Somersalo K, Saksela E. Fibronectin facilitates the migration of human natural killer cells. Eur. J. Immunol. 1991; 21: 35-42.
80. 2-integrins in the migration of human natural killer cells. J. Immunol. 1992; 149: 590-8.
81. 2 integrin activation. J. Immunol. 1996; 156: 1515-24.
82. Pinola M, Renkonen R, Majuri ML, Tiisala S, Saksela E. Characterization of the E-selectin ligand on NK cells. J. Immunol. 1994; 152: 3586-94.
83. Taub DD, Sayers TJ, Carter CRD, Ortaldo JR. α and β chemokines induce NK cell migration and enhance NK-mediated cytolysis. J. Immunol. 1995; 155: 3877-88.
84. Loetscher P, Seitz M, Clark-Lewis I, Baggiolini M, Moser B. Activation of NK cells by CC chemokines-Chemotaxis, Ca2+ mobilization, and enzyme release. J. Immunol. 1996; 156: 322-7.
85. Allavena P, Bianchi G, Zhou D et al. Induction of natural killer cell migration by monocyte chemotactic protein-1, -2 and -3. Eur. J. Immunol. 1994; 24: 3233-6.
86. Allavena P, Paganin C, Zhou D, Bianchi G, Sozzani S, Mantovani A. Interleukin-12 is chemotactic for natural killer cells and stimulates their interaction with vascular endothelium. Blood 1994; 84: 2261-8.
87. Caligiuri MA, Zmuidzinas A, Manley TJ, Levine H, Smith KA, Ritz J. Functional consequences of interleukin-2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors. J. Exp. Med. 1990; 171: 1509-26.
88. - natural killer cells in vivo. J. Exp. Med. 1990; 171: 1527-33.
89. Grabstein KH, Eisenman J, Shanebeck K et al. Cloning of a T cell growth factor that interacts with the β chain of the interleukin-2 receptor. Science 1994; 264: 965-8.
90. Dubuisson L, Fawaz R, Garcia-Barcina M et al. Ultrastructure of human liver-associated lymphocytes in vivo and in vitro. In: Bouwens L (ed.) NK Cells in the Liver. New York: Springer-Verlag, 1995: 129-54.
91. Geiselhart A, Dietl J, Marzusch K et al. Comparative analysis of the immunophenotypes of decidual and peripheral blood large granular lymphocytes and T cells during early human pregnancy. Am. J. Reprod. Immunol. 1995; 33: 315-22.
92. Slukvin II, Merkulova AA, Vodyanik MA, Chernyshov VP. Differential expression of CD45RA and CD45RO molecules on human decidual and peripheral blood lymphocytes at early stage of pregnancy. Am. J. Reprod. Immunol. 1996; 35: 16-22.
93. Pruvot FR, Navarro F, Janin A et al. Characterisation, quantification, and localisation of passenger T lymphocytes and NK cells in human liver before transplantation. Transplant. Internat. 1995; 8: 273-9.
94. Schlitt HJ, Raddatz G, Steinhoff G, Wonigeit K, Pichlmayr R. Passenger lymphocytes in human liver allografts and their potential role after transplantation. Transplantation 1993; 56: 951-5.
95. Kummer JA, Wever PC, Kamp AM, Tenberge IJM, Hack CE, Weening JJ. Expression of granzyme A and B proteins by cytotoxic lymphocytes involved in acute renal allograft rejection. Kidney Internat. 1995; 47: 70-7.
96. Ruck P, Marzusch K, Kaiserling E et al. Distribution of cell adhesion molecules in decidua of early human pregnancy - An immunohistochemical study. Lab. Invest. 1994; 71: 94-101.
97. Warren HS, Skipsey LJ. Phenotypic analysis of a resting subpopulation of human peripheral blood NK cells: The FcRγ III (CD16) molecule and NK cell differentiation. Immunology 1991; 72: 150-7.
98. Warren HS, Kinnear BF, Witt CS, Christiansen FT. Proliferation of alloreactive human natural killer cells independent of specific allogeneic stimulation. Int. Immunol. 1994; 6: 507-13.
99. Baume DM, Robertson MJ, Levine H, Manley TJ, Schow PW, Ritz J. Differential responses to interleukin 2 define functionally distinct subsets of human natural killer cells. Eur. J. Immunol. 1992; 22: 1-6.
100. Robertson MJ, Manley TJ, Donahue C, Levine H, Ritz J. Costimulatory signals are required for optimal proliferation of human natural killer cells. J. Immunol. 1993; 150: 1705-14.
101. Warren HS, Skipsey LJ. Loss of activation-induced CD45R0 with maintenance of CD45RA expression during prolonged culture of T cells and NK cells. Immunology 1991; 74: 78-85.
102. Phillips JH, Le AM, Lanier LL. Natural killer cells activated in human mixed lymphocyte response culture identified by expression of Leu 11 and class II histocompatibility antigens. J. Exp. Med. 1984; 159: 993-1008.
103. Warren HS, Pembrey RG. Cyclosporine inhibits a two signal mechanism for the generation of cytotoxic NK-like cells, from small lymphocyte precursors. Immunol. Lett. 1986; 12: 69-75.
104. Tripp CS, Wolf SF, Unanue ER. Interleukin 12 and tumour necrosis factor α are costimulators of interferon γ production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiological antagonist. Proc. Natl Acad. Sci. USA 1993; 90: 3725-9.
105. Warren HS, Kinnear BF, Skipsey LJ, Pembrey RG. Differential expression of CD45R0 on natural killer (NK) cells in patients with an NK lymphocytosis. Immunol. Cell Biol. 1994; 72: 500-7.
106. + natural killer-type lymphoproliferative disease of granular lymphocytes. Leukemia 1995; 9: 1207-11.
107. Tao Q, Ho FCS, Loke SL, Srivastava G. Epstein-Barr virus is localized in the tumour cells of nasal lymphomas of NK, T or B cell type. Int. J. Cancer 1995; 60: 315-20.
108. Kaneko T, Fukuda J, Yoshihara T et al. Nasal natural killer (NK) cell lymphoma: Report of a case with activated NK cells containing Epstein-Barr virus and expressing CD21 antigen, and comparative studies of their phenotype and cytotoxicity with normal NK cells. Br. J. Haematol. 1995; 91: 355-61.
109. Welsh RM. Cytotoxic cells induced during lymphocytic choriomeningitis virus infection in mice. I. Characterisation of natural killer cell induction. J. Exp. Med. 1978; 148: 163-81.
110. Lohler J, Gossman J, Kratzberg T, Lehmann-Grube F. Murine hepatitis caused by lymphocytic choriomeningitis virus. I. The hepatic lesions. Lab. Invest 1994; 70: 263-78.
111. Tamesis RR, Messmer EM, Rice BA, Dutt JE, Foster CS. The role of natural killer cells in the development of herpes simplex virus type-1 induced stromal keratitis in mice. Eye 1994; 8: 298-306.
112. Lemstrom K, Koskinen P, Krogerus L, Daemen M, Bruggeman C, Hayry P. Cytomegalovirus antigen expression, cndothelial cell proliferation, and intimal thickening in rat cardiac allografts after cytomegalovirus infection. Circulation 1995; 92: 2594-604.
113. Blakely ML, van der Werf WJ, Berndt MC, Dalmasso AP, Bach FH, Hancock WW. Activation of intraendothelial and mononuclear cells during discordant xenograft rejection. Transplantation 1994; 58: 1059-66.
114. Biron CA, Welsh RM. Blastogenesis of natural killer cells during infection in vivo. J. Immunol. 1982; 129: 2788-95.
115. Biron CA, Turgiss LR, Welsh RM. Increase in NK cell number and turnover rate during acute viral infection. J. Immunol. 1983; 131: 1539-45.
116. Welsh RM, Brubaker JO, Vargas-Cortes M, O'Donnell CL. Natural killer (NK) cell response to virus infections in mice with severe combined immunodeficiency. The stimulation of NK cells and the NK cell-dependent control of virus infections occur independently of T and B cell function. J. Exp. Med. 1991; 173: 1053-63.
117. Su HC, Orange JS, Fast LD et al. IL-2-dependent NK cell responses discovered in virus-infected β2-microglobulin-deficient mice. J. Immunol. 1994; 153: 5674-81.
118. + cells as effectors of IFN-γ dependent immunity to Toxoplasma-gondii in MHC class-I-defieient mice. J. Exp. Med. 1993; 178: 1465-72.
119. Karupiah G, Coupar BE, Andrew ME et al. Elevated natural killer cell responses in mice infected with recombinant vaccinia virus encoding murine IL-2. J. Immunol. 1990; 144: 290-8.
120. Karupiah G, Woodhams CE, Blanden RV, Ramshaw IA. Immunobiology of infection with recombinant vaccinia virus encoding murine IL-2. Mechanisms of rapid viral clearance in immunocompetent mice. J. Immunol. 1991; 147: 4327-32.